| Dr Lacyoni Moraes-finglass, MD | |
|
1237 W Main St, Abingdon, VA 24210-4705 | |
| (276) 676-2211 | |
| Not Available |
| Full Name | Dr Lacyoni Moraes-finglass |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1237 W Main St, Abingdon, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215918248 | NPI | - | NPPES |
| 4653146 | Other | VA | AETNA |
| 2108605 | Other | VA | MAMSI |
| P00055669 | Other | VA | RR MEDICARE |
| 010003709 | Medicaid | VA | |
| 237991 | Other | VA | SOUTHERN HEALTH |
| 010166700 | Other | VA | BLACK LUNG |
| 461931 | Other | VA | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 0101225620 (Virginia) | Primary |
| Entity Name | Johnston Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104812684 PECOS PAC ID: 6103725668 Enrollment ID: O20040103000016 |
News Archive
Death is a bigger risk than stroke among patients with atrial fibrillation, particularly during the first 4 months after diagnosis, research shows.
The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. However, many of these targeted cancer therapies have been more frequently identified for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey.
The drought and famine once again blighting the Horn of Africa brings with it an unwelcome reminder that for all of mankind's achievements we are yet to eradicate the scourge of poverty or provide clean water, sanitation or basic health care for the world's most desperate people.
ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.
Pyramidal graphs resulting from statistical analyses of EEG recordings can improve our understanding of epileptic seizures.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lacyoni Moraes-finglass, MD 19332 Triple Crown Dr, Abingdon, VA 24211-6752 Ph: (276) 676-3969 | Dr Lacyoni Moraes-finglass, MD 1237 W Main St, Abingdon, VA 24210-4705 Ph: (276) 676-2211 |
News Archive
Death is a bigger risk than stroke among patients with atrial fibrillation, particularly during the first 4 months after diagnosis, research shows.
The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. However, many of these targeted cancer therapies have been more frequently identified for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey.
The drought and famine once again blighting the Horn of Africa brings with it an unwelcome reminder that for all of mankind's achievements we are yet to eradicate the scourge of poverty or provide clean water, sanitation or basic health care for the world's most desperate people.
ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.
Pyramidal graphs resulting from statistical analyses of EEG recordings can improve our understanding of epileptic seizures.
› Verified 9 days ago
Dr. Joe Rupe, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-4050 Fax: 276-258-4056 | |
Dr. Beverly Tara Smith, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-1000 | |
Maung M. Kyi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr Ste 312c, Abingdon, VA 24211 Phone: 276-258-1985 Fax: 276-258-1989 | |
Dr. Andrew Waller, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 300 Valley St Ne, Abingdon, VA 24210 Phone: 276-206-8197 Fax: 276-206-8761 | |
Martin Monahan, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 322 E Valley St, Abingdon, VA 24210 Phone: 276-628-1106 Fax: 276-676-0215 | |
Dr. Gregory H Miller, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Suite 212a, Abingdon, VA 24211 Phone: 276-258-3740 Fax: 276-258-3745 | |
John Byron Patterson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Suite 212a, Abingdon, VA 24211 Phone: 276-258-3740 Fax: 276-258-3745 |